Viveve Medical (NASDAQ: VIVE) reported Q3 EPS of ($0.46), $0.02 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $1.85 million versus the consensus estimate of $1.55 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.